Affordable Care Act Associated With Shift to Earlier-Stage Cancer Diagnosis
May 18th 2017More Stage I cancers were diagnosed after the passage of the Affordable Care Act within 5 screenable disease types (colorectal cancer, female breast cancer, cervical cancer, lung cancer, and prostate cancer) than were diagnosed before ACA implementation.
Expert Stresses Importance of Pairing AI Treatment With Preventive Sexual Counseling
March 16th 2017During a presentation at the 2017 Miami Breast Cancer Conference, Leslie R. Schover, PhD, stressed the importance of preventive sexual counseling in reducing sexual dysfunction resulting from the treatment of breast cancer patients with aromatase inhibitors.
Axillary Lymph Node Dissection Avoidable in Some Breast Cancer Cases
February 16th 2017An axillary lymph node dissection can be avoided for patients with large, operable tumors in the breast, no clinical signs of cancer in the axillary nodes before being treated with neoadjuvant chemotherapy, and no signs of cancer following a sentinel lymph node biopsy during surgery.
Study Findings Show Role for Pembrolizumab and Durvalumab in GBM Treatment, Expert Says
November 21st 2016Based on encouraging efficacy signals and safety data from separate trials exploring the PD-1 inhibitor pembrolizumab (Keytruda) and the PD-L1 inhibitor durvalumab (MEDI4736), there is a role for checkpoint inhibitors in the treatment of glioblastoma multiforme (GBM).